Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Page 1
Hepatocytic ballooning in non-alcoholic steatohepatitis: Dilemmas and future directions.
Liver Int. 2023 Jun;43(6):1170-1182. doi: 10.1111/liv.15571. Epub 2023 Apr 5.
Liver Int. 2023.
PMID: 37017559
Review.
Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults.
Chang J, Chang Y, Cho Y, Jung HS, Park DI, Park SK, Ham SY, Wild SH, Byrne CD, Ryu S.
Chang J, et al.
Liver Int. 2023 Nov;43(11):2548-2559. doi: 10.1111/liv.15738. Epub 2023 Sep 22.
Liver Int. 2023.
PMID: 37735984
Item in Clipboard
Novel urinary protein panels for the non-invasive diagnosis of non-alcoholic fatty liver disease and fibrosis stages.
Feng G, Zhang X, Zhang L, Liu WY, Geng S, Yuan HY, Sha JC, Wang XD, Sun DQ, Targher G, Byrne CD, Zheng TL, Ye F, Zheng MH, Chai J; CHESS-MAFLD Consortium.
Feng G, et al.
Liver Int. 2023 Jun;43(6):1234-1246. doi: 10.1111/liv.15565. Epub 2023 Mar 27.
Liver Int. 2023.
PMID: 36924436
Item in Clipboard
AutoFibroNet: A deep learning and multi-photon microscopy-derived automated network for liver fibrosis quantification in MAFLD.
Zhan H, Chen S, Gao F, Wang G, Chen SD, Xi G, Yuan HY, Li X, Liu WY, Byrne CD, Targher G, Chen MY, Yang YF, Chen J, Fan Z, Sun X, Cai G, Zheng MH, Zhuo S; CHESS-MAFLD consortium.
Zhan H, et al.
Aliment Pharmacol Ther. 2023 Sep;58(6):573-584. doi: 10.1111/apt.17635. Epub 2023 Jul 4.
Aliment Pharmacol Ther. 2023.
PMID: 37403450
Item in Clipboard
Nonalcoholic fatty liver disease and risk of incident young-onset hypertension: Effect modification by sex.
Kim Y, Chang Y, Ryu S, Park S, Cho Y, Sohn W, Kang J, Wild SH, Byrne CD.
Kim Y, et al.
Nutr Metab Cardiovasc Dis. 2023 Aug;33(8):1608-1616. doi: 10.1016/j.numecd.2023.04.021. Epub 2023 Jun 2.
Nutr Metab Cardiovasc Dis. 2023.
PMID: 37357078
Item in Clipboard
Identification of individuals at risk of hepatocellular carcinoma: screening for clinically significant liver fibrosis in patients with T2DM.
Reinson T, Buchanan RM, Byrne CD.
Reinson T, et al.
Expert Rev Endocrinol Metab. 2023 Sep-Nov;18(5):355-359. doi: 10.1080/17446651.2023.2248242. Epub 2023 Aug 17.
Expert Rev Endocrinol Metab. 2023.
PMID: 37587863
No abstract available.
Item in Clipboard
Editorial: Recent advances in fibrosis assessment for metabolic dysfunction-associated fatty liver disease-Authors' reply.
Gao F, Byrne CD, Targher G, Zhuo S, Zheng MH; CHESS-MAFLD consortium.
Gao F, et al.
Aliment Pharmacol Ther. 2023 Sep;58(6):638-639. doi: 10.1111/apt.17660.
Aliment Pharmacol Ther. 2023.
PMID: 37632278
No abstract available.
Item in Clipboard
Liver fibrosis markers and all cause mortality in people with type 2 diabetes: A population based study (The Ayrshire Diabetes Outcomes Cohort (ADOC) Study).
Collier A, Curran C, Cameron L, Wild SH, Byrne CD.
Collier A, et al.
Diabetes Obes Metab. 2023 Sep;25(9):2659-2668. doi: 10.1111/dom.15153. Epub 2023 Jun 13.
Diabetes Obes Metab. 2023.
PMID: 37311724
Item in Clipboard
Cite
Cite